Agency Information Collection Activities; Proposed Collection; Comments Requested: Application for Procurement Quota for Controlled Substances and Ephedrine, Pseudoephedrine, and Phenylpropanolamine, 9429-9430 [2013-02877]
Download as PDF
<![CDATA[
Federal Register / Vol. 78, No. 27 / Friday, February 8, 2013 / Notices
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses.
sroberts on DSK5SPTVN1PROD with NOTICES
Overview of This Information
Collection 1117–0006
17:23 Feb 07, 2013
Jkt 229001
[FR Doc. 2013–02876 Filed 2–7–13; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
(1) Type of Information Collection:
Extension of a currently approved
collection.
(2) Title of the Form/Collection:
Application for Individual
Manufacturing Quota for a Basic Class
of Controlled Substance and for
Ephedrine, Pseudoephedrine, and
Phenylpropanolamine (DEA Form 189).
(3) Agency form number, if any, and
the applicable component of the
Department of Justice sponsoring the
collection: Form Number: DEA Form
189, Office of Diversion Control, Drug
Enforcement Administration,
Department of Justice.
(4) Affected public who will be asked
or required to respond, as well as a brief
abstract: Primary: Business or other forprofit.
Other: None.
Abstract: 21 U.S.C. 826 and 21 CFR
1303.22 and 1315.22 require that any
person who is registered to manufacture
any basic class of controlled substances
listed in Schedule I or II and who
desires to manufacture a quantity of
such class, or who desires to
manufacture using the List I chemicals
ephedrine, pseudoephedrine, or
phenylpropanolamine, must apply on
DEA Form 189 for a manufacturing
quota for such quantity of such class or
List I chemical.
(5) An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: DEA estimates that each form
takes 0.5 hours (30 minutes) to
complete. In total, 33 firms submit 641
responses, with each response taking 0.5
hours (30 minutes) to complete. This
results in a total public burden of 320.5
hours annually.
(6) An estimate of the total public
burden (in hours) associated with the
collection: In total, 33 firms submit 641
responses, with each response taking 0.5
hours (30 minutes) to complete. This
results in a total public burden of 320.5
hours annually.
If additional information is required
contact: Jerri Murray, Department
Clearance Officer, Policy and Planning
Staff, Justice Management Division,
Department of Justice, Two Constitution
Square, 145 N Street, NE., Room 3W–
1407B, Washington, DC 20530.
VerDate Mar<15>2010
Dated: February 5, 2013.
Jerri Murray,
Department Clearance Officer, PRA, United
States Department of Justice.
Drug Enforcement Administration
[OMB Number 1117–0008]
Agency Information Collection
Activities; Proposed Collection;
Comments Requested: Application for
Procurement Quota for Controlled
Substances and Ephedrine,
Pseudoephedrine, and
Phenylpropanolamine
ACTION:
30-day notice.
The Department of Justice (DOJ), Drug
Enforcement Administration (DEA) will
be submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
The proposed information collection is
published to obtain comments from the
public and affected agencies. This
proposed information collection was
previously published in the Federal
Register Volume 77, Number 233, page
71832 on December 4, 2012, allowing
for a 60 day comment period.
The purpose of this notice is to allow
for an additional 30 days for public
comment until March 11, 2013. This
process is conducted in accordance with
5 CFR 1320.10.
Written comments and/or suggestions
regarding the items contained in this
notice, especially the estimated public
burden and associated response time,
should be directed to the Office of
Management and Budget, Office of
Information and Regulatory Affairs,
Attention Department of Justice Desk
Officer, Washington, DC 20503.
Additionally, comments may be
submitted to OMB via facsimile to (202)
395–7285.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address one or more
of the following four points:
• Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
• Evaluate the accuracy of the
agencies estimate of the burden of the
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
9429
proposed collection of information,
including the validity of the
methodology and assumptions used;
• Enhance the quality, utility, and
clarity of the information to be
collected; and
• Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses.
Overview of This Information
Collection 1117–0008
(1) Type of Information Collection:
Extension of a currently approved
collection.
(2) Title of the Form/Collection:
Application for Procurement Quota for
Controlled Substances and Ephedrine,
Pseudoephedrine, and
Phenylpropanolamine (DEA Form 250).
(3) Agency form number, if any, and
the applicable component of the
Department sponsoring the collection:
DEA Form 250, Office of Diversion
Control, Drug Enforcement
Administration, Department of Justice.
(4) Affected public who will be asked
or required to respond, as well as a brief
abstract:
Primary: Business or other for-profit.
Other: None.
Abstract: 21 U.S.C. 826 and 21 CFR
1303.12 and 1315.32 require that U.S.
companies who desire to use any basic
class of controlled substances listed in
Schedule I or II or the List I chemicals
ephedrine, pseudoephedrine, and
phenylpropanolamine for purposes of
manufacturing during the next calendar
year shall apply on DEA Form 250 for
procurement quota for such class or List
I chemical.
(5) An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: DEA estimates that each form
takes 1⁄2 hour to complete. DEA
estimates that 419 individual
respondents will respond to this form.
DEA estimates that 2,716 responses are
received annually.
(6) An estimate of the total public
burden (in hours) associated with the
collection: The total public burden for
this collection is 1,358 hours annually.
If additional information is required
contact: Jerri Murray, Department
Clearance Officer, Policy and Planning
Staff, Justice Management Division,
Department of Justice, Two Constitution
Square, 145 N Street NE., Room 3W–
1407B, Washington, DC 20530.
E:\FR\FM\08FEN1.SGM
08FEN1
9430
Federal Register / Vol. 78, No. 27 / Friday, February 8, 2013 / Notices
Dated: February 5, 2013.
Jerri Murray,
Department Clearance Officer, PRA, United
States Department of Justice.
[FR Doc. 2013–02877 Filed 2–7–13; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[OMB Number 1117–0033]
Agency Information Collection
Activities; Proposed Collection;
Comments Requested: Report of Mail
Order Transaction
sroberts on DSK5SPTVN1PROD with NOTICES
ACTION:
30-day notice.
The Department of Justice (DOJ), Drug
Enforcement Administration (DEA), will
be submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
The proposed information collection is
published to obtain comments from the
public and affected agencies. This
proposed information collection was
previously published in the Federal
Register Volume 77, Number 236, page
73052, on December 7, 2012, allowing
for a 60-day comment period.
The purpose of this notice is to allow
for an additional 30 days for public
comment until March 11, 2013. This
process is conducted in accordance with
5 CFR 1320.10. Written comments and/
or suggestions regarding the items
contained in this notice, especially the
estimated public burden and associated
response time, should be directed to the
Office of Management and Budget,
Office of Information and Regulatory
Affairs, Attention Department of Justice
Desk Officer, Washington, DC 20503.
Additionally, comments may be
submitted to OMB via facsimile to (202)
395–7285.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address one or more
of the following four points:
• Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
• Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
VerDate Mar<15>2010
17:23 Feb 07, 2013
Jkt 229001
• Enhance the quality, utility, and
clarity of the information to be
collected; and
• Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses.
Overview of Information Collection
1117–0033
(1) Type of Information Collection:
Extension of a currently approved
collection.
(2) Title of the Form/Collection:
Report of Mail Order Transaction.
(3) Agency form number, if any, and
the applicable component of the
Department of Justice sponsoring the
collection: Form Number: none; Office
of Diversion Control, Drug Enforcement
Administration, Department of Justice.
(4) Affected public who will be asked
or required to respond, as well as a brief
abstract:
Primary: Business or other for-profit.
Other: Not-for-Profit Institutions;
State, Local or Tribal Government.
Abstract: The Comprehensive
Methamphetamine Control Act of 1996
(Pub. L. 104–237) (MCA) amended the
Controlled Substances Act to require
that each regulated person who engages
in a transaction with a non-regulated
person which involves ephedrine,
pseudoephedrine, or
phenylpropanolamine (including drug
products containing these chemicals)
and uses or attempts to use the Postal
Service or any private or commercial
carrier shall, on a monthly basis, submit
a report of each such transaction
conducted during the previous month to
the Attorney General.
(5) An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: It is estimated that there are 11
total respondents for this information
collection; three (3) for paper form at 1
hour for each response; and eight (8) via
electronic mail at 15 minutes per form,
all of which report monthly. The total
annual burden is 60 hours (36 hours for
paper forms and 24 hours for electronic
forms).
(6) An estimate of the total public
burden (in hours) associated with the
collection: It is estimated that there are
60 annual burden hours associated with
this collection.
If additional information is required
contact: Jerri Murray, Department
Clearance Officer, United States
Department of Justice, Justice
PO 00000
Frm 00074
Fmt 4703
Sfmt 4703
Management Division, Policy and
Planning Staff, Two Constitution
Square, 145 N Street NE., Room 3W–
1407B, Washington, DC 20530.
Dated: February 5, 2013.
Jerri Murray,
Department Clearance Officer for PRA, U.S.
Department of Justice.
[FR Doc. 2013–02875 Filed 2–7–13; 8:45 am]
BILLING CODE 4410–09–P
LEGAL SERVICES CORPORATION
Sunshine Act Meeting Notice
The Legal Services
Corporation’s Institutional
Advancement Committee will meet
telephonically on February 13, 2013.
The meeting will commence at 4:00
p.m., Eastern Standard Time (EST), and
will continue until the conclusion of the
Committee’s agenda.
LOCATION: F. William McCalpin
Conference Center, Legal Services
Corporation Headquarters, 3333 K Street
NW., Washington, DC 20007.
STATUS OF MEETING: Closed. Upon a vote
of the Board of Directors, the meeting
may be closed to the public to receive
a presentation on and to discuss
prospective funders for LSC’s
development activities and 40th
anniversary celebration.
A verbatim written transcript will be
made of the closed session of the Board
and Institutional Advancement
Committee meetings. The transcript of
any portions of the closed session
falling within the relevant provisions of
the Government in the Sunshine Act, 5
U.S.C. § 552b(c)(9) will not be available
for public inspection. A copy of the
General Counsel’s Certification that, in
his opinion, the closing is authorized by
law will be available upon request.
DATE AND TIME:
Matters To Be Considered
1. Presentation on and discussion of
prospective funders for LSC’s
development activities and 40th
anniversary celebration
2. Consider and act on adjournment of
meeting
CONTACT PERSON FOR INFORMATION:
Katherine Ward, Executive Assistant to
the Vice President & General Counsel, at
(202) 295–1628. Questions may be sent
by electronic mail to
FR_NOTICE_QUESTIONS@lsc.gov.
ACCESSIBILITY: LSC complies with the
Americans with Disabilities Act and
Section 504 of the 1973 Rehabilitation
Act. Upon request, meeting notices and
materials will be made available in
alternative formats to accommodate
individuals with disabilities.
E:\FR\FM\08FEN1.SGM
08FEN1
]]>Agencies
[Federal Register Volume 78, Number 27 (Friday, February 8, 2013)]
[Notices]
[Pages 9429-9430]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-02877]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[OMB Number 1117-0008]
Agency Information Collection Activities; Proposed Collection;
Comments Requested: Application for Procurement Quota for Controlled
Substances and Ephedrine, Pseudoephedrine, and Phenylpropanolamine
ACTION: 30-day notice.
-----------------------------------------------------------------------
The Department of Justice (DOJ), Drug Enforcement Administration
(DEA) will be submitting the following information collection request
to the Office of Management and Budget (OMB) for review and approval in
accordance with the Paperwork Reduction Act of 1995. The proposed
information collection is published to obtain comments from the public
and affected agencies. This proposed information collection was
previously published in the Federal Register Volume 77, Number 233,
page 71832 on December 4, 2012, allowing for a 60 day comment period.
The purpose of this notice is to allow for an additional 30 days
for public comment until March 11, 2013. This process is conducted in
accordance with 5 CFR 1320.10.
Written comments and/or suggestions regarding the items contained
in this notice, especially the estimated public burden and associated
response time, should be directed to the Office of Management and
Budget, Office of Information and Regulatory Affairs, Attention
Department of Justice Desk Officer, Washington, DC 20503. Additionally,
comments may be submitted to OMB via facsimile to (202) 395-7285.
Written comments and suggestions from the public and affected
agencies concerning the proposed collection of information are
encouraged. Your comments should address one or more of the following
four points:
Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
Evaluate the accuracy of the agencies estimate of the
burden of the proposed collection of information, including the
validity of the methodology and assumptions used;
Enhance the quality, utility, and clarity of the
information to be collected; and
Minimize the burden of the collection of information on
those who are to respond, including through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses.
Overview of This Information Collection 1117-0008
(1) Type of Information Collection: Extension of a currently
approved collection.
(2) Title of the Form/Collection: Application for Procurement Quota
for Controlled Substances and Ephedrine, Pseudoephedrine, and
Phenylpropanolamine (DEA Form 250).
(3) Agency form number, if any, and the applicable component of the
Department sponsoring the collection: DEA Form 250, Office of Diversion
Control, Drug Enforcement Administration, Department of Justice.
(4) Affected public who will be asked or required to respond, as
well as a brief abstract:
Primary: Business or other for-profit.
Other: None.
Abstract: 21 U.S.C. 826 and 21 CFR 1303.12 and 1315.32 require that
U.S. companies who desire to use any basic class of controlled
substances listed in Schedule I or II or the List I chemicals
ephedrine, pseudoephedrine, and phenylpropanolamine for purposes of
manufacturing during the next calendar year shall apply on DEA Form 250
for procurement quota for such class or List I chemical.
(5) An estimate of the total number of respondents and the amount
of time estimated for an average respondent to respond: DEA estimates
that each form takes \1/2\ hour to complete. DEA estimates that 419
individual respondents will respond to this form. DEA estimates that
2,716 responses are received annually.
(6) An estimate of the total public burden (in hours) associated
with the collection: The total public burden for this collection is
1,358 hours annually.
If additional information is required contact: Jerri Murray,
Department Clearance Officer, Policy and Planning Staff, Justice
Management Division, Department of Justice, Two Constitution Square,
145 N Street NE., Room 3W-1407B, Washington, DC 20530.
[[Page 9430]]
Dated: February 5, 2013.
Jerri Murray,
Department Clearance Officer, PRA, United States Department of Justice.
[FR Doc. 2013-02877 Filed 2-7-13; 8:45 am]
BILLING CODE 4410-09-P
